News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
Quantum BioPharma announces approval to proceed with dosing of second cohort in Lucid-21-302 trial. Company focused on innovative treatments for neurodegenerative disorders -
COMMUNIQUÉ DE PRESSE
Atlas Salt Appoints Endeavour Financial as Financial Advisor for the Project Financing of its Great Atlantic Salt Project
Atlas Salt appoints Endeavour Financial as financial advisor for securing project financing for the Great Atlantic Salt Project. Landmark achievements in 2024 fortify Company's position for financing -
COMMUNIQUÉ DE PRESSE
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections
VisiRose, a clinical-stage biotechnology company, collaborates with Bascom Palmer Eye Institute to introduce Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT) for eye infections. The innovative treatment addresses antimicrobial resistance and offers hope for patients worldwide -
COMMUNIQUÉ DE PRESSE
Granite Creek Copper Confirms New Mineralized Zone in 2024 Drilling at Carmacks Copper-Gold-Silver Project in Yukon, Canada
Granite Creek Copper announces successful drill results from new Gap Zone at Carmacks project in Yukon, showing promising copper mineralization potential for resource expansion and extended mine life -
-
